Blackstone buys Japan drug trial firm, adding to private equity health deals
Blackstone has been increasingly active in Japan’s life science sector amid a wider buyout boom in the country.
Tomas Kauer - News Moderator 
Blackstone has been increasingly active in Japan’s life science sector amid a wider buyout boom in the country.
